Telomere dysfunction drives aberrant hematopoietic differentiation and myelodysplastic syndrome
- PMID: 25965571
- PMCID: PMC4596059
- DOI: 10.1016/j.ccell.2015.04.007
Telomere dysfunction drives aberrant hematopoietic differentiation and myelodysplastic syndrome
Abstract
Myelodysplastic syndrome (MDS) risk correlates with advancing age, therapy-induced DNA damage, and/or shorter telomeres, but whether telomere erosion directly induces MDS is unknown. Here, we provide the genetic evidence that telomere dysfunction-induced DNA damage drives classical MDS phenotypes and alters common myeloid progenitor (CMP) differentiation by repressing the expression of mRNA splicing/processing genes, including SRSF2. RNA-seq analyses of telomere dysfunctional CMP identified aberrantly spliced transcripts linked to pathways relevant to MDS pathogenesis such as genome stability, DNA repair, chromatin remodeling, and histone modification, which are also enriched in mouse CMP haploinsufficient for SRSF2 and in CD34(+) CMML patient cells harboring SRSF2 mutation. Together, our studies establish an intimate link across telomere biology, aberrant RNA splicing, and myeloid progenitor differentiation.
Copyright © 2015 Elsevier Inc. All rights reserved.
Figures
Comment in
-
Charting the "Splice" Routes to MDS.Cancer Cell. 2015 May 11;27(5):607-9. doi: 10.1016/j.ccell.2015.04.016. Cancer Cell. 2015. PMID: 25965565
References
-
- Akashi K, Traver D, Miyamoto T, Weissman IL. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 2000;404:193–197. - PubMed
-
- Allsopp RC, Morin GB, DePinho RA, Harley CB, Weissman IL. Telomerase is required to slow telomere shortening and extend replicative lifespan of HSCs during serial transplantation. Blood. 2003;102:517–520. - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous
